Remedia's patent on Topical Antifungals is approved by Rospatent

Antareit, Remedia's gastroenterology product, receives approval in Russia

Remedia receives approval from Indian regulators for phase III clinical study for new drug

Remedia receives marketing authorization in Russia for two of its products, Flucorem and Remebrox